Dual perfluorocarbon method to noninvasively monitor dissolved oxygen concentration in tissue engineered constructs in vitro and in vivo

Biotechnology Progress

Volumn 27, Issue 4, 2011, Pages 1115-1125

  Goh, Fernie ^a   Long, Robert ^b   Simpson, Nicholas ^c   Sambanis, Athanassios ^a,d  

^a Georgia Institute of Technology   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

TC tet; 19F nuclear magnetic resonance; Dissolved oxygen; Perfluorocarbon; Tissue construct

Indexed keywords

19F NUCLEAR MAGNETIC RESONANCE; ALGINATE BEADS; CULTURE MEDIUM; DISSOLVED OXYGEN CONCENTRATIONS; HOST CELLS; IN-VITRO; IN-VIVO; KEY PARAMETERS; MATHEMATICAL SIMULATIONS; MONITORING METHODS; OXYGEN CONCENTRATIONS; PERFLUOROCARBON; PERFLUOROCARBONS; PHYSIOLOGIC CONDITIONS; STATIC CONDITIONS; SURROUNDING ENVIRONMENT; TISSUE CONSTRUCT; TISSUE CONSTRUCTS; TISSUE ENGINEERED CONSTRUCTS; TISSUE FUNCTION; TISSUE IMPLANTS;

CELL CULTURE; CELLS; DISSOLUTION; GROWTH KINETICS; MAMMALS; MONITORING; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGENATION; PHYSIOLOGY; RESONANCE; TISSUE;

DISSOLVED OXYGEN;

DIAGNOSTIC AGENT; FLUOROCARBON; OXYGEN;

ANIMAL; ARTICLE; METABOLISM; MOUSE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; THEORETICAL MODEL; TISSUE ENGINEERING; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; FLUOROCARBONS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MODELS, THEORETICAL; OXYGEN; TISSUE ENGINEERING;

ANIMALIA; MURINAE; MUS;

EID: 79961028856     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.619     Document Type: Article

References (52)

1. Stabler CL, Long RC Jr. Constantinidis I, Sambanis A. In vivo noninvasive monitoring of a tissue engineered construct using 1H NMR spectroscopy. Cell Transplant. 2005; 14: 139-149.
2. Gross JD, Long RC Jr, Constantinidis I, Sambanis A. Monitoring of dissolved oxygen and cellular bioenergetics within a pancreatic substitute. Biotechnol Bioeng. 2007; 98: 261-270.
3. Mason RP. Non-invasive physiology: 19F NMR of perfluorocarbons. Artif Cells Blood Substit Immobil Biotechnol. 1994; 22: 1141-1153.
4. Diaz-Lopez R, Tsapis N, Fattal E. Liquid perfluorocarbons as contrast agents for ultrasonography and F-19-MRI. Pharmaceut Res. 2010; 27: 1-16.
5. Reid RS, Koch CJ, Castro ME, Lunt JA, Treiber EO, Boisvert DJ, Allen PS. The influence of oxygenation on the 19F spin-lattice relaxation rates of fluosol-DA. Phys Med Biol. 1985; 30: 677-686.
6. Parhami P, Fung BM. F-19 Relaxation study of perfluoro chemicals as oxygen carriers. J Phys Chem. 1983; 87: 1928-1931.
7. Riess JG. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artif Cells Blood Substit Biotechnol. 2005; 33: 47-63.
8. Johnson A, Fisher, RJ, Weir, GC, Colton, CK. Oxygen consumption and diffusion in assemblages of respiring spheres: performance enhancement of a bioartificial pancreas. Chem Eng Sci. 2009; 64: 4470-4487.
9. Khattak SF, Chin KS, Bhatia SR, Roberts SC. Enhancing oxygen tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons. Biotechnol Bioeng. 2007; 96: 156-166.
10. Chin K, Khattak SF, Bhatia SR, Roberts SC. Hydrogel-perfluorocarbon composite scaffold promotes oxygen transport to immobilized cells. Biotechnol Prog. 2008; 24: 358-366.
11. Goh F, Gross, JD, Simpson, NE, Sambanis, A. Limited beneficial effects of perfluorocarbon emulsions on encapsulated cells in culture: experimental and modeling studies. J Biotechnol. 2010; 150: 232-239.
12. Papas KK, Long RC Jr, Constantinidis I, Sambanis A. Effects of oxygen on metabolic and secretory activities of beta TC3 cells. Biochim Biophys Acta. 1996; 1291: 163-166.
13. Papas KK, Long RC Jr, Constantinidis I, Sambanis A. Effects of short-term hypoxia on a transformed cell-based bioartificial pancreatic construct. Cell Transplant. 2000; 9: 415-422.
14. Ryu GR, Lee MK, Lee E, Ko SH, Ahn YB, Kim JW, Yoon KH, Song KH. Activation of AMP-activated protein kinase mediates acute and severe hypoxic injury to pancreatic beta cells. Biochem Biophys Res Commun. 2009; 386: 356-362.
15. de Groot M, Schuurs TA, Keizer PP, Fekken S, Leuvenink HG, van Schilfgaarde R. Response of encapsulated rat pancreatic islets to hypoxia. Cell Transplant. 2003; 12: 867-875.
16. Dionne KE, Colton CK, Yarmush ML. Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes. 1993; 42: 12-21.
17. Giuliani M, Moritz W, Bodmer E, Dindo D, Kugelmeier P, Lehmann R, Gassmann M, Groscurth P, Weber M. Central necrosis in isolated hypoxic human pancreatic islets: evidence for postisolation ischemia. Cell Transplant. 2005; 14: 67-76.
18. Lau J, Henriksnas J, Svensson J, Carlsson PO. Oxygenation of islets and its role in transplantation. Curr Opin Organ Transplant. 2009; 14: 688-693.
19. Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes. 2002; 51: 66-72.
20. de Groot M, Schuurs TA, van Schilfgaarde R. Causes of limited survival of microencapsulated pancreatic islet grafts. J Surg Res. 2004; 121: 141-150.
21. Emamaullee JA, Shapiro AM. Factors influencing the loss of beta-cell mass in islet transplantation. Cell Transplant. 2007; 16: 1-8.
22. Papas KK, Pisania A, Wu H, Weir GC, Colton CK. A stirred microchamber for oxygen consumption rate measurements with pancreatic islets. Biotechnol Bioeng. 2007; 98: 1071-1082.
23. Zacharovova K, Berkova Z, Spacek T, Kriz J, Dovolilova E, Girman P, Koblas T, Jezek P, Saudek F. In vitro assessment of pancreatic islet vitality by oxymetry. Transplant Proc. 2005; 37: 3454-3456.
24. Papas KK, Long RC, Sambanis A, Constantinidis I. Development of a bioartificial pancreas: II. Effects of oxygen on long-term entrapped beta TC3 cell cultures. Biotechnol Bioeng. 1999; 66: 231-237.
25. Jorjani P, Ozturk SS. Effects of cell density and temperature on oxygen consumption rate for different mammalian cell lines. Biotechnol Bioeng. 1999; 64: 349-356.
26. Papas KK, Colton CK, Nelson RA, Rozak PR, Avgoustiniatos ES, Scott WE III, Wildey GM, Pisania A, Weir GC, Hering BJ. Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice. Am J Transplant. 2007; 7: 707-713.
27. Sweet IR, Gilbert M, Jensen R, Sabek O, Fraga DW, Gaber AO, Reems J. Glucose stimulation of cytochrome c reduction and oxygen consumption as assessment of human islet quality. Transplantation. 2005; 80: 1003-1011.
28. Scholz AW, Eberle B, Heussel CP, David M, Schmittner MD, Quintel M, Schreiber LM, Weiler N. Ventilation-perfusion ratio in perflubron during partial liquid ventilation. Anesth Analg. 2010; 110: 1661-1668.
29. Thomas SR, Pratt RG, Millard RW, Samaratunga RC, Shiferaw Y, McGoron AJ, Tan KK. In vivo PO2 imaging in the porcine model with perfluorocarbon F-19 NMR at low field. Magn Reson Imaging. 1996; 14: 103-114.
30. Shukla HP, Mason RP, Bansal N, Antich PP. Regional myocardial oxygen tension: 19F MRI of sequestered perfluorocarbon. Magn Reson Med. 1996; 35: 827-833.
31. Noth U, Rodrigues LM, Robinson SP, Jork A, Zimmermann U, Newell B, Griffiths JR. In vivo determination of tumor oxygenation during growth and in response to carbogen breathing using 15C5-loaded alginate capsules as fluorine-19 magnetic resonance imaging oxygen sensors. Int J Radiat Oncol Biol Phys. 2004; 60: 909-919.
32. McNab JA, Yung AC, Kozlowski P. Tissue oxygen tension measurements in the Shionogi model of prostate cancer using 19F MRS and MRI. MAGMA. 2004; 17: 288-295.
33. Noth U, Grohn P, Jork A, Zimmermann U, Haase A, Lutz J. F-19-MRI in vivo determination of the partial oxygen pressure in perfluorocarbon-loaded alginate capsules implanted into the peritoneal cavity and different tissues. Magn Reson Med. 1999; 42: 1039-1047.
34. Goh F, Gross JD, Simpson NE, Sambanis A. Limited beneficial effects of perfluorocarbon emulsions on encapsulated cells in culture: experimental and modeling studies. J Biotechnol. 2010; 150: 232-239.
35. Efrat S, Fusco-DeMane D, Lemberg H, al Emran O, Wang X. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci U S A. 1995; 92: 3576-3580.
36. Stabler C, Wilks K, Sambanis A, Constantinidis I. The effects of alginate composition on encapsulated betaTC3 cells. Biomaterials. 2001; 22: 1301-1310.
37. Papas KK, Constantinidis I, Sambanis A. Cultivation of recombinant, insulin-secreting AtT-20 cells as free and entrapped spheroids. Cytotechnology. 1993; 13: 1-12.
38. Lim F, Sun AM. Microencapsulated Islets as Bioartificial Endocrine Pancreas. Science. 1980; 210: 908-910.
39. Joseph PM, Fishman JE, Mukherji B, Sloviter HA. In vivo 19F NMR imaging of the cardiovascular system. J Comput Assist Tomogr. 1985; 9: 1012-1019.
40. Thomas SR, Pratt RG, Millard RW, Samaratunga RC, Shiferaw Y, Clark LCJr., Hoffmann RE. Evaluation of the influence of the aqueous phase bioconstituent environment on the F-19 T1 of perfluorocarbon blood substitute emulsions. J Magn Reson Imaging. 1994; 4: 631-635.
41. Berkowitz BA, Handa JT, Wilson CA. Perfluorocarbon temperature-measurements using F-19 NMR. NMR Biomed. 1992; 5: 65-68.
42. Gross JD, Constantinidis I, Sambanis A. Modeling of encapsulated cell systems. J Theor Biol. 2007; 244: 500-510.
43. Safley SA, Cui H, Cauffiel S, Tucker-Burden C, Weber CJ. Biocompatibility and immune acceptance of adult porcine islets transplanted intraperitoneally in diabetic NOD mice in calcium alginate poly-L-lysine microcapsules versus barium alginate microcapsules without poly-L-lysine. J Diabetes Sci Technol. 2008; 2: 760-767.
44. Duvivier-Kali VF, Omer A, Parent RJ, O'Neil JJ, Weir GC. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes. 2001; 50: 1698-1705.
45. Raquel Diaz-Lopez NT, Fattal E. Liquid perfluorocarbons as contrast agents for ultrasonography and 19F-MRI. Pharm Res. 2010; 27: 1-16.
46. Kim HW, Greenburg AG. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status. Artif Organs. 2004; 28: 813-828.
47. Zimmermann U, Noth U, Grohn P, Jork A, Ulrichs K, Lutz J, Haase A. Non-invasive evaluation of the location, the functional integrity and the oxygen supply of implants: 19F nuclear magnetic resonance imaging of perfluorocarbon-loaded Ba2+-alginate beads. Artif Cells Blood Substit Immobil Biotechnol. 2000; 28: 129-146.
48. Stabler C, Wilks K, Sambanis A, Constantinidis I. The effects of alginate composition on encapsulated beta TC3 cells. Biomaterials. 2001; 22: 1301-1310.
49. Radisic M, Deen W, Langer R, Vunjak-Novakovic G. Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol. 2005; 288: H1278-H1289.
50. Tziampazis E, Sambanis A. Tissue engineering of a bioartificial pancreas: modeling the cell environment and device function. Biotechnol Prog. 1995; 11: 115-126.
51. 2 in fluorinated ethers. J Chem Eng Data. 1973; 18: 411-412.
52. Lowe KC, Davey MR, Power JB. Perfluorochemicals: their applications and benefits to cell culture. Trends Biotechnol. 1998; 16: 272-277.